1. Home
  2. CTSO vs DXLG Comparison

CTSO vs DXLG Comparison

Compare CTSO & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.72

Market Cap

49.7M

Sector

Health Care

ML Signal

HOLD

Logo Destination XL Group Inc.

DXLG

Destination XL Group Inc.

HOLD

Current Price

$1.12

Market Cap

49.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
DXLG
Founded
1997
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
49.7M
49.6M
IPO Year
N/A
1987

Fundamental Metrics

Financial Performance
Metric
CTSO
DXLG
Price
$0.72
$1.12
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.38
$2.50
AVG Volume (30 Days)
126.1K
64.0K
Earning Date
11-13-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,979,520.00
$447,744,000.00
Revenue This Year
$9.51
N/A
Revenue Next Year
$24.40
$3.95
P/E Ratio
N/A
N/A
Revenue Growth
23.89
N/A
52 Week Low
$0.60
$0.88
52 Week High
$1.61
$3.10

Technical Indicators

Market Signals
Indicator
CTSO
DXLG
Relative Strength Index (RSI) 46.64 65.07
Support Level $0.70 $0.90
Resistance Level $0.85 $1.00
Average True Range (ATR) 0.07 0.07
MACD 0.01 0.03
Stochastic Oscillator 52.04 74.29

Price Performance

Historical Comparison
CTSO
DXLG

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About DXLG Destination XL Group Inc.

Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.

Share on Social Networks: